Human
mesenchymal stem cells inhibit differentiation and function of monocyte - derived dendritic cells.
Mesenchymal stem cells inhibit the expression of CD25 [interleukin - 2 receptor] and CD38 on phytohaemagglutinin - activated lymphocytes.
Rasmusson I, Ringden O, Sundberg B, Le Blanc K.
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.
Not exact matches
«Our study suggests that ALDH1A3 is a potentially functional biomarker for
mesenchymal glioma
stem cells, and that
inhibiting that enzyme might offer a promising therapeutic approach for high - grade gliomas that have a
mesenchymal signature,» says principal investigator Ichiro Nakano, MD, PhD, associate professor of neurosurgery at the OSUCCC — James.
Inhibiting ALDH1A3 - mediated pathways slows the growth of
mesenchymal glioma
stem cells and might provide a promising therapeutic approach for glioblastomas with a
mesenchymal signature.